Recurrent Thrombotic Events after Discontinuation of Vitamin K Antagonist Treatment for Splanchnic Vein Thrombosis: A Multicenter Retrospective Cohort Study

It is generally recommended that patients with splanchnic vein thrombosis (SVT) should receive a minimum of 3 months of anticoagulant treatment. However, little information is available on the long-term risk of recurrent thrombotic events. The aim of this study was to evaluate the risk of venous and...

Descripción completa

Detalles Bibliográficos
Autores principales: Riva, Nicoletta, Ageno, Walter, Poli, Daniela, Testa, Sophie, Rupoli, Serena, Santoro, Rita, Lerede, Teresa, Piana, Antonietta, Carpenedo, Monica, Nicolini, Alberto, Ferrini, Piera Maria, Martini, Giuliana, Mangione, Catello, Contino, Laura, Bonfanti, Carlo, Gresele, Paolo, Tosetto, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609867/
https://www.ncbi.nlm.nih.gov/pubmed/26508913
http://dx.doi.org/10.1155/2015/620217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609867/
https://www.ncbi.nlm.nih.gov/pubmed/26508913
http://dx.doi.org/10.1155/2015/620217

Ejemplares similares